|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-09
|
$3,860,269
|
$772,054
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Emory-GA Tech Nanotechnology Center for Personalized an*
|
5U54CA119338-04
|
$3,600,018
|
$180,001
|
NIE, SHUMING
|
EMORY UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-33
|
$2,910,583
|
$291,058
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-26
|
$2,908,648
|
$581,730
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
SPORE in Prostate Cancer
|
5P50CA092629-08
|
$2,715,008
|
$1,357,504
|
SCARDINO, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Targeting Vessels in Tumors
|
5P01CA104898-04
|
$2,637,795
|
$263,780
|
SCHNITZER, JAN
|
SIDNEY KIMMEL CANCER CENTER
|
|
SPORE in Genitourinary Cancer
|
5P50CA091846-08
|
$2,489,653
|
$497,931
|
DINNEY, COLIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
THE THERAPY OF AML
|
5P01CA055164-16
|
$2,374,635
|
$118,732
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-07
|
$2,327,870
|
$116,394
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
SPORE In Protate Cancer
|
2P50CA058236-14
|
$2,300,000
|
$253,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
2P50CA100632-06
|
$2,300,000
|
$184,000
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas SPORE in Lung Cancer
|
2P50CA070907-11
|
$2,300,000
|
$276,000
|
MINNA, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Yale SPORE in Skin Cancer
|
5P50CA121974-03
|
$2,233,298
|
$66,999
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-04
|
$2,180,817
|
$545,204
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-09
|
$2,180,816
|
$872,326
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Prostate Cancer
|
5P50CA091956-08
|
$2,179,681
|
$871,872
|
TINDALL, DONALD
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-05
|
$2,163,322
|
$540,831
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Pacific Ovarian Cancer Research Consortium
|
5P50CA083636-10
|
$2,089,524
|
$522,381
|
URBAN, NICOLE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-14
|
$2,080,053
|
$1,560,040
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Epithelial Ovarian Cancer Program Project
|
5P01CA052477-16
|
$2,037,296
|
$203,730
|
SPRIGGS, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Mixed Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-10
|
$2,003,834
|
$500,959
|
Storb, Rainer
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetic Approaches to Cancer Immunotherapy
|
5P01CA059350-15
|
$1,998,048
|
$859,161
|
SADELAIN, MICHEL
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$19,065
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Enhancing T Cell Therapy of Cancer
|
2P01CA094237-06
|
$1,905,870
|
$1,124,463
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
MSKCC Center for Molecular Imaging in Cancer
|
5P50CA086438-08
|
$1,904,290
|
$190,429
|
Blasberg, Ronald
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-09
|
$1,890,657
|
$472,664
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Tumor Hypoxia Imaging - Laboratory and Clinical Studies
|
5P01CA115675-03
|
$1,863,192
|
$465,798
|
LING, CLIFTON
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,703,170
|
$17,032
|
Wayne, Alan
|
CCR (NCI)
|
|
Clinical and Laboratory Studies of Malignant Lymphomas
|
5P01CA034233-24
|
$1,681,253
|
$403,501
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA037447-25
|
$1,580,095
|
$63,204
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-09
|
$1,575,134
|
$393,784
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Extension of Radiotherapy Research
|
5P01CA006294-44
|
$1,516,143
|
$1,516,143
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Molecular Basis of Viral and Cellular Transformation
|
5P01CA016038-35
|
$1,474,958
|
$147,496
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
$144,610
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
PRECLINICAL IN VITRO AND IN VIVO SCREENING ASSAYS FOR CANCER PREVENTIVE AGENT DEV
|
N01CN433002-005
|
$1,415,128
|
$141,513
|
LIPKIN, MARTIN
|
STRANG CANCER PREVENTION CENTER:1106275
|
|
Mechanisms for Chemoprevention of Cancer
|
5P01CA077839-10
|
$1,384,110
|
$276,822
|
DUBOIS, RAYMOND
|
VANDERBILT UNIVERSITY
|
|
Gene Therapy for Brain Tumors
|
5P01CA069246-12
|
$1,371,426
|
$1,371,426
|
HOCHBERG, FRED
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Gene and Radiation Therapies for Cancer
|
5P01CA097012-05
|
$1,350,392
|
$1,350,392
|
FREYTAG, SVEND
|
HENRY FORD HEALTH SYSTEM
|
|
Combinatorial Chemistry and Cancer Target
|
5P01CA078045-10
|
$1,341,169
|
$402,351
|
VOGT, PETER
|
SCRIPPS RESEARCH INSTITUTE
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
7P01CA104177-04
|
$1,329,682
|
$664,841
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Prostate Cancer: Transition to Androgen-Independence
|
5P01CA077739-09
|
$1,227,045
|
$98,164
|
FRENCH, FRANK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
GENOMIC IMPRINTING AND THE CLONING OF MICE
|
5R37CA084198-09
|
$1,226,340
|
$367,902
|
JAENISCH, RUDOLF
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-12
|
$1,200,734
|
$1,200,734
|
Albelda, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
5U10CA035178-25
|
$1,198,666
|
$11,987
|
Lange, Marianne
|
SPECTRUM HEALTH HOSPITALS
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
Z01 BC 010336
|
$1,151,600
|
$287,900
|
Court, Donald
|
CCR (NCI)
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
Z01 BC 010984
|
$1,116,265
|
$446,506
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
Z01 BC 010985
|
$1,116,265
|
$446,506
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Mouse Models of Myeloid Leukemia
|
5U01CA084221-10
|
$1,055,331
|
$263,833
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Prevention & Metastasis: Final Frontiers in Colon Cancer
|
5U01CA084239-10
|
$1,051,364
|
$525,682
|
COFFEY, ROBERT
|
VANDERBILT UNIVERSITY
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-22
|
$1,042,698
|
$10,427
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
Total relevant funding to Gene Therapy for this search: $76,968,945
|